Glenview State Bank Trust Department’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Glenview State Bank Trust Department’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-16,790	Closed	-$12K	–	122
2020 Q4	$12K	Buy	16,790 +130	+0.8%	+$277	﹤0.01%	119
2020 Q3	$37K	Sell	16,660 -320	-2%	-$914	0.01%	106
2020 Q2	$61K	Sell	16,980 -200	-1%	-$722	0.03%	106
2020 Q1	$65K	Sell	17,180 -200	-1%	-$659	0.03%	97
2019 Q4	$51K	Buy	+17,380	New	+$45.2K	0.02%	111

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

WAM

Westport Asset Management Southport, Connecticut $245M AUM 15.03% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Glenview State Bank Trust Department's BMY.RT Position: Q1 2021 in Review

Glenview State Bank Trust Department sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 16,790 shares — an estimated $12K sold.

Glenview State Bank Trust Department first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $65K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

Glenview State Bank Trust Department reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
Glenview State Bank Trust Department sold 16,790 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $12K.
Glenview State Bank Trust Department first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
Glenview State Bank Trust Department's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $65K in Q1 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Glenview State Bank Trust Department's 13F filing for Q1 2021, filed 3 May 2021.